See All Slides - tctmd.com

Slides

Presentation TCT 2015

3-D Imaging Is Crucial for Mitral Valve Assessment and Interventional Guidance

Presenter: Robert J. Siegel, Neil J. Weissman, Samir R. Kapadia

October 11, 2015

Presentation TCT 2015

Adventitial Injection Therapy for Restenosis: Rationale and Clinical Results to Date

Presenter: Prakash Krishnan, Mahmood K. Razavi, Christopher D. Owens

October 11, 2015

Presentation TCT 2015

The Retrograde Approach: UK CTO Registry Insights

Presenter: J. Aaron Grantham, Masahiko Ochiai, William M Wilson

October 11, 2015

Presentation TCT 2015

Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Yes, and the Data Are Strong for Clopidogrel and Prasugrel (DAPT Trial)!

Presenter: C. Michael Gibson, Marco Valgimigli, Robert W. Yeh

October 11, 2015

Presentation TCT 2015

Lesion Characteristics From the Different Devices: Do They Differ?

Presenter: Juan F. Granada, Michael Joner

October 11, 2015

Presentation TCT 2015

Nuances of DMR vs FMR Imaging and Quantification

Presenter: Robert J. Siegel, Neil J. Weissman

October 11, 2015

Presentation TCT 2015

Czech Republic Presents: The ACS Patient Czech Republic Registry

Presenter: George D. Dangas, Eric Van Belle, Martin Maly

October 11, 2015

Presentation TCT 2015

What Are Bioresorbable Scaffolds (BRS), and Why Do We Need Them?

Presenter: Thomas H. Maloney, Ron Waksman

October 11, 2015

Presentation TCT 2015

The Retrograde Approach: PROGRESS CTO Insights

Presenter: J. Aaron Grantham, Masahiko Ochiai, Khaldoon Alaswad

October 11, 2015

Presentation TCT 2015

Step-by-Step Approach to Assessing MR: An Integrative Approach

Presenter: Robert J. Siegel, Neil J. Weissman

October 11, 2015

Advertisement

Slides

3-D Imaging Is Crucial for Mitral Valve Assessment and Interventional Guidance

Adventitial Injection Therapy for Restenosis: Rationale and Clinical Results to Date

The Retrograde Approach: UK CTO Registry Insights

Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Yes, and the Data Are Strong for Clopidogrel and Prasugrel (DAPT Trial)!

Lesion Characteristics From the Different Devices: Do They Differ?

Nuances of DMR vs FMR Imaging and Quantification

Czech Republic Presents: The ACS Patient Czech Republic Registry

What Are Bioresorbable Scaffolds (BRS), and Why Do We Need Them?

The Retrograde Approach: PROGRESS CTO Insights

Step-by-Step Approach to Assessing MR: An Integrative Approach

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content